Clinical Research Directory
Browse clinical research sites, groups, and studies.
Qishenyiqi for Ventricular Remodeling After Myocardial Infarction
Sponsor: Qilu Hospital of Shandong University
Summary
The effects of Qishenyiqi dripping pill on cardiac remodeling in patients with chronic stable heart failure have not been reported. This project aims to clarify the efficacy and safety of Qishenyiqi in patients with chronic heart failure after myocardial infarction. Patients with chronic stable heart failure after myocardial infarction were selected and randomly divided into two groups: the treatment group was treated with Qishenyiqi dripping pills; The control group was given placebo treatment. After 12 months of follow-up, the effects of Qishenyiqi on cardiac remodeling and function and cardiovascular adverse events were evaluated. The results are helpful to provide a new treatment strategy for chronic heart failure.
Official title: Efficacy and Safety of Qishenyiqi Dripping Pills in Patients With Ventricular Remodeling and Chronic Heart Failure With Reduced Ejection Fraction After Myocardial Infarction
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2024-11-20
Completion Date
2027-12-31
Last Updated
2024-11-21
Healthy Volunteers
No
Conditions
Interventions
Qishenyiqi dripping pills
Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months
Placebo
Placebo, 1 bag once, three times a day, 12 months
Locations (3)
Panpan Hao
Jinan, Shandong, China
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, China